Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Eva E. Raschke"'
Autor:
Eva E. Raschke, Dirk Eick, Guido T. Bommer, Conny Kuklik-Roos, Bettina Kempkes, Elisabeth Dumont, Marino Schuhmacher, Manuela Horndasch
Publikováno v:
International Journal of Cancer. 101:442-447
TGF-beta induces apoptosis and inhibits the proliferation of EBV-negative B-lymphoma cell lines. In contrast, EBV-immortalized B cells are resistant to both the proapoptotic and the antiproliferative activities of TGF-beta. We have generated a lympho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30938b819e35b3e5cea252ca65bbe251
https://doi.org/10.1002/ijc.10626
https://doi.org/10.1002/ijc.10626
Autor:
Michael Meisterernst, Jens Oliver Funk, Eva E. Raschke, Andrea Pullner, Julie Wells, Thomas J. Albert, Dirk Eick, Gertraud Stelzer, Peggy J. Farnham
Publikováno v:
Journal of Biological Chemistry. 276:20482-20490
The proto-oncogene c-myc is transcribed from a dual promoter P1/P2, with transcription initiation sites 160 base pairs apart. Here we have studied the transcriptional activation of both promoters on chromatin templates. c-myc chromatin was reconstitu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7626ce4d180ab63233415b191497610
https://doi.org/10.1074/jbc.m100265200
https://doi.org/10.1074/jbc.m100265200
Publikováno v:
The Journal of Immunology. 163:4375-4382
Transcriptional regulation can occur at the level of initiation and RNA elongation. We report that the rearranged, nontranscribed Igκ gene in the pre-B cell line 70Z/3 harbors a paused RNA polymerase II (pol II) at a position between 45 and 89 bp do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6513ad90686d71535cc112e556797ae3
https://doi.org/10.4049/jimmunol.163.8.4375
https://doi.org/10.4049/jimmunol.163.8.4375
Autor:
Schildknecht K; Ivana Türbachova Laboratory for Epigenetics, Epiontis, Precision for Medicine GmbH, Berlin, Germany., Samans B; Ivana Türbachova Laboratory for Epigenetics, Epiontis, Precision for Medicine GmbH, Berlin, Germany., Gussmann J; Ivana Türbachova Laboratory for Epigenetics, Epiontis, Precision for Medicine GmbH, Berlin, Germany., Baron U; Ivana Türbachova Laboratory for Epigenetics, Epiontis, Precision for Medicine GmbH, Berlin, Germany., Raschke E; Ivana Türbachova Laboratory for Epigenetics, Epiontis, Precision for Medicine GmbH, Berlin, Germany., Babel N; Marienhospital Herne, Klinik I für Innere Medizin, Centrum für Translationale Medizin, Herne, Germany., Oppatt J; Ivana Türbachova Laboratory for Epigenetics, Epiontis, Precision for Medicine GmbH, Berlin, Germany., Gellhaus K; Bundesinstitut für Risikobewertung, Berlin, Germany., Rossello A; Ivana Türbachova Laboratory for Epigenetics, Epiontis, Precision for Medicine GmbH, Berlin, Germany., Janack I; Ivana Türbachova Laboratory for Epigenetics, Epiontis, Precision for Medicine GmbH, Berlin, Germany., Olek S; Ivana Türbachova Laboratory for Epigenetics, Epiontis, Precision for Medicine GmbH, Berlin, Germany.
Publikováno v:
Clinical chemistry and laboratory medicine [Clin Chem Lab Med] 2023 Nov 21; Vol. 62 (4), pp. 615-626. Date of Electronic Publication: 2023 Nov 21 (Print Publication: 2024).
Autor:
Burska AN; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Thu A; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Parmar R; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Bzoma I; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Samans B; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Raschke E; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Olek S; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Conaghan PG; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Emery P; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Ponchel F; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Publikováno v:
Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2019 Nov 01; Vol. 58 (11), pp. 2015-2024.
Autor:
Barth SD; Affiliations of authors: Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (SDB, TK, AH, TJ, RK); Ivana Türbachova Labor für Epigenetik, Epiontis GmbH, Berlin, Germany (JJS, ER, SO)., Schulze JJ; Affiliations of authors: Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (SDB, TK, AH, TJ, RK); Ivana Türbachova Labor für Epigenetik, Epiontis GmbH, Berlin, Germany (JJS, ER, SO)., Kühn T; Affiliations of authors: Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (SDB, TK, AH, TJ, RK); Ivana Türbachova Labor für Epigenetik, Epiontis GmbH, Berlin, Germany (JJS, ER, SO)., Raschke E; Affiliations of authors: Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (SDB, TK, AH, TJ, RK); Ivana Türbachova Labor für Epigenetik, Epiontis GmbH, Berlin, Germany (JJS, ER, SO)., Hüsing A; Affiliations of authors: Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (SDB, TK, AH, TJ, RK); Ivana Türbachova Labor für Epigenetik, Epiontis GmbH, Berlin, Germany (JJS, ER, SO)., Johnson T; Affiliations of authors: Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (SDB, TK, AH, TJ, RK); Ivana Türbachova Labor für Epigenetik, Epiontis GmbH, Berlin, Germany (JJS, ER, SO)., Kaaks R; Affiliations of authors: Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (SDB, TK, AH, TJ, RK); Ivana Türbachova Labor für Epigenetik, Epiontis GmbH, Berlin, Germany (JJS, ER, SO)., Olek S; Affiliations of authors: Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (SDB, TK, AH, TJ, RK); Ivana Türbachova Labor für Epigenetik, Epiontis GmbH, Berlin, Germany (JJS, ER, SO).
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2015 Aug 22; Vol. 107 (11). Date of Electronic Publication: 2015 Aug 22 (Print Publication: 2015).